A high-pressure liquid chromatography (HPLC) method has been developed for the analysis of cefazolin in serum. Serum was deproteinized by the addition of6% trichloroacetic acid and injected onto a reverse-phase column with a mobile phase of 10 to 15% methanol in 1% aqueous acetic acid. Cefazolin chromatographed without interference from ultraviolet-absorbing components of serum, with a retention time of 3.1 min. Standard curves comparing peak area with concentration prepared from dog or human sera were linear over a range of 1.6 to 200 ug/ml. Results from the HPLC assay were compared with microbiological assays (cylinder plate method) on both standard serum samples and sera from dogs and human subjects receiving intramuscular cefazolin. The HPLC method was somewhat more accurate in comparison with the microbiological assay performed on serum samples of known concentration. The comparison of results from an analysis of serum levels of dogs or human subjects receiving cefazolin indicated that the two methods would lead to identical conclusions concerning pharmacokinetics or the achievement of therapeutic serum levels. The HPLC assay method presents an alternative to conventional microbiological assays, with marked improvement in speed (30 min) and considerable potential for future development.
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The antibiotics as a class are unique among drugs or xenobiotics in that the analytical methods used in the routine determination of serum levels have involved bioassay rather than chemical methodology.
Cephalosporins are a widely used group of drugs that have traditionally been assayed in serum by microbiological assays. Sera from patients, clinical pharmacology test subjects, or experimental animals receiving cephalosporings are usually assayed by the disk plate, cylinder plate, or agar well diffusion methods, which depend on the inhibition of growth of Bacillus subtilis or Sarcina lutea.
The conventional methods routinely used for drug assay in serum, such as gas chromatographic, photometric, or fluorometric methods, have not been applied to the cephalosporins, except to a very limited extent. Tune (5) determined cephaloridine concentrations in serum by a method involving the fluorometric determination of pyridine released by acid hydrolysis. Mullen et al, (3) reported an indirect method for the determination of cephaloridine, involving the gas chromatographic determination ofpyridine released by alkaline hydrolysis. 
RESULTS
Chromatography. Representative chromatographic tracings resulting from the injection of samples prepared from blank dog serum or from dog serum containing 20 ug of cefazolin sodium per ml are shown in Fig. 1 . The chromatographic conditions provided adequate separation of the cefazolin peak from ultravioletabsorbing components of the serum sample. Control serum contained no interfering ultraviolet-absorbing components. Chromatography of blank and cefazolin-containing samples of human serum was identical to the results described for dog serum.
Standard curves. The reproducibility and linearity of a standard curve generated from ANTIMICROB. AGENTS CHEMOTHER. dog or human serum containing various amounts of cefazolin sodium are shown in Fig.  2 . The standard curve represents triplicate analyses. A standard curve was prepared daily from single analyses at each concentration. When higher serum concentrations were expected, standard curves were prepared over a concentration range of 10 to 200 ug/ml, with a full-scale absorbance at an optical density of 0.04 with similar reproducibility and linearity.
The reproducibility of the analytical method was demonstrated by the analysis of 12 portions of blank human serum containing cefazolin sodium at a concentration of 25 ,ug/ml assayed against a standard curve prepared from single samples containing 5, 10, 20, 30, and 50 ug of cefazolin sodium per ml. The resultant data gave a mean of 24.3 ,ug/ml, with a standard deviation of 1.2 and a coefficient of variation of 4.9%. The range of values was from 21.9 to 26.6 ,ug/ml. (ii) Serum levels. Serum samples from dogs receiving 10 mg of cefazolin per kg intramuscularly and human subjects receiving 1-g intramuscular doses were analyzed by both HPLC and microbiological methods. The resultant serum level-time curves are presented in Fig. 3  and 4 .
There is generally good agreement between the two assay methods. The correlation coefficient between the HPLC and microbiological assay in dog and human sera over all time points was 0.96. The HPLC technique gave slightly higher values at most time points although the agreement between the two methods was better at the lower serum levels observed in dogs (Fig. 3) .
In cases in which there was a significant discrepancy between the two methods, as shown in Fig. 4 (subject F, 3 h) , the HPLC assay appeared to give a more reasonable value since there is no pharmacokinetically logical explanation for a rise in the serum level from 3 to 4 h, as indicated by the microbiological assay.
DISCUSSION
The liquid chromatographic analysis of cefazolin in serum offers an alternative to the conventional microbiological assay. The HPLC method is accurate and reproducible and appears to give results that are at least comparable to or perhaps slightly better than the microbiological assay. The differences between the results obtained by the two methods are not of a great enough magnitude, however, to alter any 
